Recent Advances in the Use of Functional Foods: Effects of the Commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt Strains on Gut Transit Time in the Elderly

Fermented milk products containing the probiotic strain Bifidobacterium animalis DN-173 010 (BM) have a beneficial effect in reducing gut transit times in a range of populations including adults and the elderly, especially female. The aims of this study were to investigate the efficacy of one and tw...

Full description

Saved in:
Bibliographic Details
Published in:Microbial ecology in health and disease 2003-01, Vol.15 (1), p.15-22
Main Authors: Meance, Séverine, Cayuela, Chantal, Raimondi, Aldo, Turchet, Pietro, Lucas, Claudio, Antoine, Jean-michel
Format: Article
Language:English
Subjects:
Bifidobacterium Animalis Strain Dn-173 010
Biological and medical sciences
domain_sdv.mp.prb
domain_sdv.mp.prb.bif
Feeding. Feeding behavior
Food industries
Functional Food
Fundamental and applied biological sciences. Psychology
Gut Transit Time
Lactobacillus Delbrueckii Bulgaricus
Life Sciences
Microbiology and Parasitology
Probiotic
Research and development. New food products, dietetic foods and beverages
Streptococcus Thermophilus
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fermented milk products containing the probiotic strain Bifidobacterium animalis DN-173 010 (BM) have a beneficial effect in reducing gut transit times in a range of populations including adults and the elderly, especially female. The aims of this study were to investigate the efficacy of one and two servings per day of BM in elderly subjects and to determine the duration of the reduction in transit times after stopping consumption of the product. This was a randomized controlled and open study with four groups; 200 elderly subjects (aged 50-75 years) were enrolled in the trial. In all, 100 subjects with medium transit times (MTT, 40-50 h) and 100 with slow transit times (STT, >50 h) were randomized to receive either 125 g or 250 g BM daily for 2 weeks. Oro-faecal gut transit was determined by the use of coloured markers. Both dosages significantly reduced oro-faecal transit time with reductions of 20.5% and 42.2% observed in MTT subjects receiving BM 125 g/day and 250 g/day, respectively ( p
ISSN:0891-060X
1651-2235
1651-2235
1234-987X
DOI:10.1080/08910600310015565